逆流検査製品市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、適応疾患別、エンドユーザー別、地域別、競合別、2020～2030年

逆流検査製品の世界市場規模は2024年に36億5,000万米ドルで、予測期間中のCAGRは5.02%で2030年には49億1,000万米ドルに達すると予測されています。

世界の逆流検査製品市場は、広範な医療産業の中でダイナミックかつ急速に発展しているセグメントです。逆流検査製品は、医療専門家が胃食道逆流症（GERD）やその他の関連疾患を診断・管理するために使用する重要なツールです。この市場には、pHモニタリングシステム、インピーダンスpHモニタリングシステム、食道内圧測定装置、関連アクセサリなど、幅広い診断機器と消耗品が含まれます。

逆流検査製品世界市場の成長促進要因の一つは、GERDと関連疾患の世界の有病率の増加です。不健康なライフスタイル、肥満、食習慣などの要因が酸逆流の罹患率上昇に寄与しているため、正確な診断ツールに対する需要が高まっています。高齢化社会は食道障害を引き起こしやすく、市場の拡大をさらに後押ししています。

技術の進歩は、食道疾患の市場形成に極めて重要な役割を果たしています。センサ技術、ワイヤレス接続、データ分析の革新は診断手順の精度と利便性を高め、患者の転帰と診断精度の向上につながりました。低侵襲診断技術へのシフトが先進的な逆流検査製品の採用を促進し、患者により低侵襲で快適な体験を提供しています。最近の動向では、家庭用逆流検査キットなど、患者中心の診断ソリューションの開発が重視されるようになってきており、市場に新たな機会を創出するものと期待されています。さらに、医療機器メーカーと医療プロバイダーとの協業は、逆流検査製品の入手しやすさと手頃な価格を確保することで、市場の成長を促進すると考えられます。

主要市場促進要因

胃食道逆流症（GERD）の有病率の上昇

主要市場課題

コスト制約

主要市場動向

低侵襲技術へのシフト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の逆流検査製品市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（カテーテルベースの検査製品、カプセルベースの検査製品、逆流検査プローブ、その他）
  • 疾患別（バレット食道、逆流性食道炎、食道腺がん）
  • エンドユーザー別（病院クリニック、外来手術センター、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の逆流検査製品市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の逆流検査製品市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の逆流検査製品市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の逆流検査製品市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの逆流検査製品市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（該当する場合）
• 製品の発売（該当する場合）

第13章 ポーターのファイブフォース分析

• 産業内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Reflux Testing Products Market was valued at USD 3.65 Billion in 2024 and is expected to reach USD 4.91 Billion by 2030 with a CAGR of 5.02% during the forecast period. The Global Reflux Testing Products Market is a dynamic and rapidly evolving sector within the broader healthcare industry. Reflux testing products are essential tools used by medical professionals to diagnose and manage gastroesophageal reflux disease (GERD) and other related conditions. This market encompasses a wide range of diagnostic devices and consumables, including pH monitoring systems, impedance-pH monitoring systems, esophageal manometry equipment, and associated accessories.

One of the key drivers of growth in the Global Reflux Testing Products Market is the increasing prevalence of GERD and related disorders worldwide. Factors such as unhealthy lifestyles, obesity, and dietary habits have contributed to a rising incidence of acid reflux, thereby fuelling the demand for accurate diagnostic tools. The aging population is prone to esophageal disorders, further boosting the market's expansion.

Technological advancements have played a pivotal role in shaping the landscape of reflux testing products. Innovations in sensor technology, wireless connectivity, and data analysis have enhanced the precision and convenience of diagnostic procedures, leading to improved patient outcomes and diagnostic accuracy. The shift towards minimally invasive diagnostic techniques has driven the adoption of advanced reflux testing products, offering patients a less invasive and more comfortable experience. In recent years, there has been a growing emphasis on the development of patient-centric diagnostic solutions, including home-based reflux testing kits, which are expected to create new opportunities in the market. Moreover, collaborations between medical device manufacturers and healthcare providers are likely to drive market growth by ensuring accessibility and affordability of reflux testing products.

Key Market Drivers

Rising Prevalence of gastroesophageal reflux disease (GERD)

The rising prevalence of gastroesophageal reflux disease (GERD) is a significant driver behind the growth of the Global Reflux Testing Products Market. GERD is a chronic digestive disorder characterized by the frequent and recurrent flow of stomach acid into the esophagus, leading to uncomfortable symptoms like heartburn, regurgitation, and chest pain. This condition has become increasingly common in recent years, affecting millions of individuals worldwide.

Several factors contribute to the escalating prevalence of GERD. Unhealthy dietary habits, including the consumption of high-fat, spicy, and acidic foods, as well as excessive alcohol and caffeine intake, have been linked to the development of GERD. Furthermore, the global rise in obesity rates has added to the burden of GERD, as excess body weight can increase abdominal pressure, pushing stomach contents into the esophagus. According to Journal of Neurogastroenterology and Motility , GERD is a chronic and widespread condition. A recent systematic review found its prevalence to range from 18.1% to 27.8% in North America, 8.8% to 25.9% in Europe, 2.5% to 7.8% in East Asia, 8.7% to 33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America. The rising prevalence of GERD can be attributed to various factors, including older age, male gender, ethnicity, the use of analgesics, consumption of specific foods and beverages, a decrease in Helicobacter pylori infection rates, smoking, family history, high body mass index (BMI), and low physical activity levels. Many of these risk factors are closely tied to lifestyle choices.

Sedentary lifestyles and prolonged periods of sitting, often associated with modern working environments, can also contribute to GERD. Individuals spending long hours at desks or in front of screens may be more prone to experiencing acid reflux symptoms. As awareness of GERD and its potential complications has grown, more individuals are seeking medical attention and diagnosis. This surge in patient visits to healthcare professionals has driven the demand for reflux testing products. Accurate diagnosis is essential for proper management, as GERD can lead to serious complications, including Barrett's esophagus and esophageal cancer if left untreated.

In response to the increasing prevalence of GERD, the Global Reflux Testing Products Market has expanded to provide innovative and advanced diagnostic tools. These tools include pH monitoring systems, impedance-pH monitoring systems, and other cutting-edge devices designed to precisely assess and diagnose GERD. Additionally, the market has seen the development of patient-friendly, minimally invasive testing options, which encourage individuals to seek diagnosis and treatment.

Key Market Challenges

Cost Constraints

One of the primary factors contributing to cost constraints in the reflux testing products market is the high manufacturing costs associated with advanced diagnostic tools. Devices such as pH monitoring systems and impedance-pH monitoring systems are technologically sophisticated, requiring precision engineering and high-quality materials. The intricate sensors, data processing components, and wireless connectivity capabilities all contribute to elevated manufacturing expenses.

Apart from initial manufacturing costs, the maintenance and calibration of reflux testing products can be expensive. These devices must undergo regular servicing and calibration to ensure their accuracy. Healthcare facilities that offer reflux testing services are burdened with the recurring cost of maintaining and updating their equipment, which, in turn, can lead to higher prices for patients.

The availability of comprehensive insurance coverage for reflux testing procedures varies widely across regions and healthcare plans. Many insurance providers do not fully cover the costs of reflux testing, leaving patients to bear a substantial portion of the financial burden. This lack of adequate insurance coverage can discourage individuals from pursuing reflux testing, particularly those with limited financial resources.

The cost constraints in the reflux testing products market have implications for the accessibility and affordability of these diagnostic tools. In regions with limited healthcare resources, including lower- and middle-income countries, the high cost of reflux testing products can significantly limit their availability. As a result, individuals in these areas may not have access to essential diagnostic services.

Key Market Trends

Shift Towards Minimally Invasive Techniques

The Global Reflux Testing Products Market has witnessed a significant boost due to the ongoing trend towards minimally invasive diagnostic techniques. Traditional methods for diagnosing gastroesophageal reflux disease (GERD), such as invasive endoscopy and barium swallow studies, often involve uncomfortable and invasive procedures that can discourage patients from seeking diagnosis and treatment. This has led to a growing preference among both healthcare providers and patients for less invasive and more patient-friendly alternatives, thereby fuelling the demand for reflux testing products.

Minimally invasive reflux testing products, such as wireless pH monitoring systems and impedance-pH monitoring systems, have become increasingly popular due to their ability to provide accurate diagnostic data without the need for intrusive procedures. These devices offer patients a more comfortable experience, as they can be worn for extended periods without interfering with daily activities. This patient-centric approach not only enhances patient acceptance but also encourages individuals to seek timely diagnosis and treatment for their GERD symptoms. In June 2022, Glenmark Pharmaceuticals Ltd completed the acquisition of approved generic versions of select over-the-counter medications from Wockhardt Ltd in the United States. This acquisition was executed through Glenmark Pharmaceuticals Inc., USA, a wholly owned subsidiary of the company. The acquired assets encompass approved abbreviated new drug applications (ANDAs), including famotidine tablets (10 mg and 20 mg), which are utilized for the treatment and prevention of stomach and intestinal ulcers, indigestion, heartburn, as well as Lansoprazole delayed-release capsules USP, 15 mg, among other pharmaceutical products.

Key Market Players

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

Report Scope:

In this report, the Global Reflux Testing Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reflux Testing Products Market, By Product Type:

• Catheter Based Testing Products
• Capsule Based Testing Products
• Reflux Testing Probes
• Other

Reflux Testing Products Market, By Disease Indication:

• Barrett's Esophagus
• Reflux Esophagitis
• Esophageal Adenocarcinoma

Reflux Testing Products Market, By End User:

• Hospitals &Clinics
• Ambulatory Surgical Centers
• Other

Global Reflux Testing Products Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Reflux Testing Products Market.

Available Customizations:

Global Reflux Testing Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reflux Testing Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Catheter Based Testing Products, Capsule Based Testing Products, Reflux Testing Probes, Others)
  • 5.2.2. By Disease Indication (Barrett's Esophagus, Reflux Esophagitis, Esophageal Adenocarcinoma)
  • 5.2.3. By End User (Hospitals &Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Reflux Testing Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Disease Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reflux Testing Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Disease Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Reflux Testing Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Disease Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Reflux Testing Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Disease Indication
      • 6.3.3.2.3. By End User

7. Europe Reflux Testing Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Disease Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Reflux Testing Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Disease Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Reflux Testing Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Disease Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Reflux Testing Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Disease Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. France Reflux Testing Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Disease Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Reflux Testing Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Disease Indication
      • 7.3.5.2.3. By End User

8. Asia-Pacific Reflux Testing Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Disease Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Reflux Testing Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Disease Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Reflux Testing Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Disease Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Reflux Testing Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Disease Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Reflux Testing Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Disease Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Reflux Testing Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Disease Indication
      • 8.3.5.2.3. By End User

9. South America Reflux Testing Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Disease Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Reflux Testing Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Disease Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Reflux Testing Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Disease Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Reflux Testing Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Disease Indication
      • 9.3.3.2.3. By End User

10. Middle East and Africa Reflux Testing Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Disease Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Reflux Testing Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Disease Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Reflux Testing Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Disease Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Reflux Testing Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Disease Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Medtronic Plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Sierra Instruments, Inc.
• 14.3. Respiratory Technology Corporation
• 14.4. Ethicon, Inc.
• 14.5. Medical Measurement Systems BV
• 14.6. AstraZeneca Plc
• 14.7. Diversatek, Inc.
• 14.8. FLSmidth A/S
• 14.9. Laborie Medical Technologies Corp.
• 14.10. DRG Instruments GmbH

15. Strategic Recommendations

16. About Us & Disclaimer